Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$216M |
| 2 |
Apple
AAPL
|
+$215M |
| 3 |
KeyCorp
KEY
|
+$212M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$210M |
| 5 |
Synchrony
SYF
|
+$204M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$1.82B |
| 2 |
Comcast
CMCSA
|
+$427M |
| 3 |
Amazon
AMZN
|
+$418M |
| 4 |
SLB Ltd
SLB
|
+$312M |
| 5 |
Ameren
AEE
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.36% |
| 2 | Energy | 10.86% |
| 3 | Financials | 9.53% |
| 4 | Consumer Discretionary | 9.42% |
| 5 | Technology | 9.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3301
Veru
VERU
$45M
| $48K | ﹤0.01% |
3,276
-7,445
| -69% | -$122K |
|
3302
VolitionRx Ltd
VNRX
$5.69M
| $48K | ﹤0.01% |
536
-807
| -60% | -$68.5K |
|
3303
Microvision
MVIS
$50.8M
| $46K | ﹤0.01% |
+1,075
| New | +$45.1K |
|
|
AVH
3304
DELISTED
AVIANCA HOLDINGS S.A.
AVH
| $45K | ﹤0.01% |
+10,604
| New | +$46.3K |
|
|
ARO
3305
DELISTED
Aeropostale Inc
ARO
| $45K | ﹤0.01% |
160,086
-1,114,146
| -87% | -$611K |
|
|
AENZ
3306
DELISTED
Aenza S.A.A.
AENZ
| $44K | ﹤0.01% |
4,977
-2,798
| -36% | -$29.4K |
|
|
MNI
3307
DELISTED
The McClatchy Company Class A Common Stock
MNI
| $44K | ﹤0.01% |
3,619
-13,046
| -78% | -$174K |
|
|
IMN
3308
DELISTED
Imation
IMN
| $44K | ﹤0.01% |
+32,182
| New | +$59K |
|
3309
Achieve Life Sciences
ACHV
$822M
| $43K | ﹤0.01% |
16
-34
| -68% | -$144K |
|
3310
Anixa Biosciences
ANIX
$126M
| $42K | ﹤0.01% |
14,109
-21,892
| -61% | -$76.8K |
|
3311
Harvard Bioscience
HBIO
$34.1M
| $41K | ﹤0.01% |
+1,174
| New | +$40.2K |
|
3312
Inuvo
INUV
$12M
| $41K | ﹤0.01% |
+1,512
| New | +$43.5K |
|
|
FWM
3313
DELISTED
FAIRWAY GROUP HLDGS CORP CL A COM STK (DE)
FWM
| $41K | ﹤0.01% |
61,956
-29,344
| -32% | -$32.5K |
|
3314
First Majestic Silver
AG
$10.4B
| $40K | ﹤0.01% |
12,232
-1,059,111
| -99% | -$3.6M |
|
|
KEM
3315
DELISTED
KEMET Corporation
KEM
| $40K | ﹤0.01% |
16,720
-70,995
| -81% | -$193K |
|
3316
Hovnanian Enterprises
HOV
$770M
| $39K | ﹤0.01% |
867
-833
| -49% | -$39.9K |
|
3317
NanoViricides
NNVC
$33.9M
| $39K | ﹤0.01% |
1,658
-5,687
| -77% | -$136K |
|
|
TAT
3318
DELISTED
TransAtlantic Petroleum LTD.
TAT
| $38K | ﹤0.01% |
+27,107
| New | +$53.6K |
|
3319
Cineverse
CNVS
$60.1M
| $37K | ﹤0.01% |
713
-1,382
| -66% | -$124K |
|
3320
Dare Bioscience
DARE
$15.9M
| $35K | ﹤0.01% |
104
-86
| -45% | -$35.7K |
|
|
HNR
3321
DELISTED
Harvest Natural Resources
HNR
| $33K | ﹤0.01% |
19,292
-14,703
| -43% | -$54.9K |
|
3322
Network-1 Technologies
NTIP
$35.9M
| $32K | ﹤0.01% |
15,296
-15,813
| -51% | -$32.7K |
|
|
CGRN
3323
DELISTED
Capstone Green Energy Corporation Common Stock
CGRN
| $32K | ﹤0.01% |
2,271
-12,928
| -85% | -$372K |
|
3324
Galectin Therapeutics
GALT
$371M
| $30K | ﹤0.01% |
18,279
-53,866
| -75% | -$123K |
|
3325
PEDEVCO
PED
$184M
| $29K | ﹤0.01% |
+502
| New | +$21.5K |
|
Similar funds
Israel Englander's Q4 2015 Portfolio in Review
As of Q4 2015, Israel Englander held 4,144 positions worth $47.6B, down 7.9% from $51.6B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Israel Englander withdrew a net $5.89B in Q4 2015, closing 778 positions and reducing 1,349 holdings. Its most notable exit was Illumina, an estimated $86.9M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 13% a quarter earlier, followed by Energy and Financials.
Against the trend, Israel Englander opened a new position in Alphabet (Google) Class A worth $221M.
- Israel Englander's largest Q4 2015 buy was Alphabet (Google) Class A: 5,673,120 shares worth $221M.
- Israel Englander added most to Merck in Q4 2015, an estimated $216M increase.
- Israel Englander's biggest Q4 2015 reduction was DuPont de Nemours, cutting an estimated $1.82B.
- Israel Englander fully exited Illumina in Q4 2015, selling an estimated $86.9M.
- Israel Englander's ten largest holdings make up 10% of its $47.6B portfolio in Q4 2015.
- Israel Englander opened 733 new positions and closed 778 in Q4 2015.
- Israel Englander's portfolio value fell 7.9% quarter-over-quarter to $47.6B.
Based on Millennium Management's 13F filing for Q4 2015, filed 16 Feb 2016.